Background: This study was performed to investigate the early and late outcomes of total aortic arch replacement (TAR) with or without coronary artery bypass grafting (CABG).

Methods: From October 1999 to December 2010, 200 consecutive patients underwent elective TAR for nondissecting aneurysm through a median sternotomy. Of this number, 131 (65.5%) had isolated TAR (TAR group) and 69 (34.5%) underwent concomitant CABG (TAR/CABG group). Patients in the TAR/CABG group were older and had more advanced chronic kidney disease and higher additive/logistic European System for Cardiac Operative Risk Evaluation and Japan scores than patients in the TAR group.

Results: Overall 30-day mortality was 0.5% (1 of 200) and hospital mortality was 3.5% (7 of 200). Hospital mortality was 1.5% (2 of 131) in the TAR group and 7.2% (5 of 69) in the TAR/CABG group (p=0.036). Multivariate analysis showed that operation time (odds ratio [OR] 1.01, p=0.013) was a risk factor for hospital mortality, but failed to demonstrate concomitant CABG as a risk factor. Cox proportional hazard analysis showed that age (OR 1.08, p=0.05), female sex (OR 3.58, p=0.0004), chronic kidney disease (OR 7.70, p<0.0001), and operation time (OR 1.01, p=0.0002) were risk factors for midterm mortality, whereas concomitant CABG was not (OR 0.92, p=0.87). There was a significant difference in midterm survival and freedom from major cerebrocardiovascular events in the TAR group versus the TAR/CABG group.

Conclusions: Concomitant CABG was not a risk factor for hospital morality with TAR. However, patients with concomitant CABG have more preoperative comorbidities, which may adversely affect outcomes, and which may therefore deserve special attention.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.athoracsur.2012.04.034DOI Listing

Publication Analysis

Top Keywords

tar/cabg group
12
hospital mortality
12
total aortic
8
aortic arch
8
arch replacement
8
coronary artery
8
artery bypass
8
bypass grafting
8
tar group
8
concomitant cabg
8

Similar Publications

Introduction: The benefit of total arterial revascularization (TAR) in coronary artery bypass grafting (CABG) remains a controversial issue. This study sought to evaluate whether there is any difference on the long-term results of TAR and non-TAR CABG patients.

Methods: The Medical Literature Analysis and Retrieval System Online (MEDLINE), Excerpta Medica dataBASE (EMBASE), Cochrane Central Register of Controlled Trials (CENTRAL/CCTR), Clinical Trials.

View Article and Find Full Text PDF

Long-term Outcomes Associated With Total Arterial Revascularization vs Non-Total Arterial Revascularization.

JAMA Cardiol

May 2020

Schulich Heart Centre, Sunnybrook Health Sciences Centre, Division of Cardiac Surgery, Department of Surgery, University of Toronto, Toronto, Ontario, Canada.

Article Synopsis
  • The study investigates the long-term clinical outcomes of total arterial revascularization (TAR) compared to traditional methods (non-TAR) for coronary artery bypass grafting (CABG) in patients with multivessel coronary artery disease.
  • Conducted in Ontario, Canada, from 2008 to 2017, the study followed 49,404 patients, with a focus on those undergoing primary isolated CABG and including at least one arterial graft.
  • Results showed no significant difference in in-hospital mortality rates between TAR and non-TAR groups, but TAR involved more arterial grafts, indicating potential benefits in long-term outcomes worth further analysis.*
View Article and Find Full Text PDF

Background: This study was performed to investigate the early and late outcomes of total aortic arch replacement (TAR) with or without coronary artery bypass grafting (CABG).

Methods: From October 1999 to December 2010, 200 consecutive patients underwent elective TAR for nondissecting aneurysm through a median sternotomy. Of this number, 131 (65.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!